These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8008969)

  • 21. Possible use of similar framework region amino acid sequences between human and mouse immunoglobulins for humanizing mouse antibodies.
    Wu TT; Kabat EA
    Mol Immunol; 1992 Sep; 29(9):1141-6. PubMed ID: 1495500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
    Ruff-Jamison S; Glenney JR
    Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties.
    Pommié C; Levadoux S; Sabatier R; Lefranc G; Lefranc MP
    J Mol Recognit; 2004; 17(1):17-32. PubMed ID: 14872534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural effects of framework mutations on a humanized anti-lysozyme antibody.
    Holmes MA; Buss TN; Foote J
    J Immunol; 2001 Jul; 167(1):296-301. PubMed ID: 11418663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS; Air GM
    Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
    Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
    J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region.
    Mageed RA; Harmer IJ; Wynn SL; Moyes SP; Maziak BB; Brüggemann M; MacKworth-Young CG
    Clin Exp Immunol; 2001 Jan; 123(1):1-8. PubMed ID: 11167990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of the diversity region YYGS motif in anti-DNA antibody binding to DNA.
    Mahmoudi M; Bell DA; Cairns E
    Ann N Y Acad Sci; 1995 Sep; 764():424-6. PubMed ID: 7486557
    [No Abstract]   [Full Text] [Related]  

  • 30. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs.
    Potter KN; Li Y; Capra JD
    J Immunol; 1996 Oct; 157(7):2982-8. PubMed ID: 8816406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular modeling of antibody-combining sites.
    Webster DM; Rees AR
    Methods Mol Biol; 1995; 51():17-49. PubMed ID: 7581695
    [No Abstract]   [Full Text] [Related]  

  • 33. VH and VL region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum.
    Anker R; Zavala F; Pollok BA
    Eur J Immunol; 1990 Dec; 20(12):2757-61. PubMed ID: 2125276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humanization of monoclonal antibodies by CDR grafting.
    O'Brien S; Jones T
    Methods Mol Biol; 2003; 207():81-100. PubMed ID: 12412469
    [No Abstract]   [Full Text] [Related]  

  • 35. Three-dimensional structure of an Fv from a human IgM immunoglobulin.
    Fan ZC; Shan L; Guddat LW; He XM; Gray WR; Raison RL; Edmundson AB
    J Mol Biol; 1992 Nov; 228(1):188-207. PubMed ID: 1447781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.
    Bond CJ; Marsters JC; Sidhu SS
    J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4.
    Attanasio R; Kanda P; Stunz GW; Buck DW; Kennedy RC
    Mol Immunol; 1993 Jan; 30(1):9-17. PubMed ID: 8417378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions.
    Sanz I
    J Immunol; 1991 Sep; 147(5):1720-9. PubMed ID: 1908883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of surface accessible residues in human and murine immunoglobulin Fv domains. Implication for humanization of murine antibodies.
    Pedersen JT; Henry AH; Searle SJ; Guild BC; Roguska M; Rees AR
    J Mol Biol; 1994 Jan; 235(3):959-73. PubMed ID: 7507176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant shark natural antibodies to thyroglobulin.
    Schluter SF; Jensen I; Ramsland PA; Marchalonis JJ
    J Mol Recognit; 2005; 18(5):404-12. PubMed ID: 15954089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.